EU‐ARCCS: SORAFENIB CLINICAL BENEFIT IN
PATIENTS ≥ 70 YEARS
All patients
(N = 1148)
< 70 years
(n = 881)
≥ 70 years
(n = 267)
Median PFS, months (95% CI)
6.9
(6.2–7.5)
6.4
(6.0–7.3)
8.2
(6.5–8.9)
Clinical benefit* (%)
(95% CI)
77.1
(74.4–79.6)
77.0
(73.9–79.8)
77.6
(71.7–82.8)
*Defined as patients who achieved a CR, PR, or SD by radiologic or clinical assessment for ≥ 12 weeks
Bracarda S, et al. EAU 2009 [Abstract 142]
